Drug that kills off sleeping bone cells could treat lower back pain
An existing drug that targets senescent, or sleeping cells could provide the answer to treating lower back pain, according to a new study.
The research, published today as a Reviewed Preprint in eLife, advances our understanding of the role of senescent osteoclasts – cells that break down and remove damaged bone tissue – in the development of lower back pain, which affects 8 in 10 people at some point in their lives. eLife’s editors say the study provides compelling evidence that an existing drug, Navitoclax, can eliminate senescent osteoclasts in mice and, in doing so, markedly reduce spinal pain.
Osteoclasts resorb ...








